HK2 and cancer: The upregulation of PKM2 expression, which is often associated with increased glycolytic enzymes or glucose transporters (e.g., HK2, GLUT), was described at tissue level in various cancers (e.g., in breast, lung, ovarian, bladder, colon cancers).